FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

897411000168101: asfotase alfa (AU substance)

Status: current, Primitive. Date: 31-Mar 2017. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
1831091000168118 asfotase alfa (AU substance) en Fully specified name Active Case sensitive Australian Medicines Terminology module
1831101000168111 asfotase alfa en Synonym Active Case sensitive Australian Medicines Terminology module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
asfotase alfa Is a medicinal substance true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
asfotase alfa has intended active ingredient True asfotase alfa Inferred relationship Some 1
asfotase alfa 80 mg/0.8 mL injection, vial has Australian BoSS True asfotase alfa Inferred relationship Some 1728045680
asfotase alfa 80 mg/0.8 mL injection, vial has intended active ingredient True asfotase alfa Inferred relationship Some 1728045680
Strensiq 40 mg/mL injection, vial has intended active ingredient True asfotase alfa Inferred relationship Some 518321104
Strensiq 40 mg/mL injection, vial has Australian BoSS True asfotase alfa Inferred relationship Some 518321104
Strensiq 80 mg/0.8 mL injection, 0.8 mL vial has Australian BoSS True asfotase alfa Inferred relationship Some 1756658128
Strensiq 80 mg/0.8 mL injection, 0.8 mL vial has intended active ingredient True asfotase alfa Inferred relationship Some 1756658128
asfotase alfa 40 mg/mL injection, vial has intended active ingredient True asfotase alfa Inferred relationship Some 527014192
asfotase alfa 40 mg/mL injection, vial has Australian BoSS True asfotase alfa Inferred relationship Some 527014192
Strensiq 18 mg/0.45 mL injection, 0.45 mL vial has Australian BoSS True asfotase alfa Inferred relationship Some 1195199472
Strensiq 18 mg/0.45 mL injection, 0.45 mL vial has intended active ingredient True asfotase alfa Inferred relationship Some 1195199472
asfotase alfa 18 mg / 0.45 mL injection, 0.45 mL vial (medicinal product unit of use) has intended active ingredient True asfotase alfa Inferred relationship Some 1792931376
asfotase alfa 18 mg / 0.45 mL injection, 0.45 mL vial (medicinal product unit of use) has Australian BoSS True asfotase alfa Inferred relationship Some 1792931376
asfotase alfa 12 mg/0.3 mL injection, vial has Australian BoSS True asfotase alfa Inferred relationship Some 1206713104
asfotase alfa 12 mg/0.3 mL injection, vial has intended active ingredient True asfotase alfa Inferred relationship Some 1206713104
Strensiq 12 mg/0.3 mL injection, 0.3 mL vial has Australian BoSS True asfotase alfa Inferred relationship Some 291698864
Strensiq 12 mg/0.3 mL injection, 0.3 mL vial has intended active ingredient True asfotase alfa Inferred relationship Some 291698864
Strensiq 28 mg/0.7 mL injection, 0.7 mL vial has Australian BoSS True asfotase alfa Inferred relationship Some 325395088
Strensiq 28 mg/0.7 mL injection, 0.7 mL vial has intended active ingredient True asfotase alfa Inferred relationship Some 325395088
asfotase alfa 28 mg/0.7 mL injection, vial has Australian BoSS True asfotase alfa Inferred relationship Some 676443920
asfotase alfa 28 mg/0.7 mL injection, vial has intended active ingredient True asfotase alfa Inferred relationship Some 676443920

This concept is not in any reference sets

Back to Start